Surface Oncology to Present at the 39th Annual Cowen Healthcare Conference

    NEXT STORY
    Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference
    PREV STORY
    Ascendis Pharma Announces Once-weekly TransCon™ Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017, and Provides Corporate Update

    RANCHO CORDOVA, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...

    author_avatar
    NASDAQ Market News

    Zealand Pharma completes equity investment in strategic partner Beta Bionics

    Press release – No. 1 / 2019 Zealand Pharma completes equity investment in strategic ...

    author_avatar
    NASDAQ Market News

    BioXcel Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

    author_avatar
    NASDAQ Market News